Home News Insights Trading halts Paper trading Guide Community My account

Market calendarChecking market schedule

Display in USD

Loading news article.

About WAPE
U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

Phathom Pharmaceuticals Announces $0 Co-Pay Program for VOQUEZNA via BlinkRx | WAPE

Back All news

Newsfiscal.ai

Phathom Pharmaceuticals Announces $0 Co-Pay Program for VOQUEZNA via BlinkRx

Nov 3, 2026, 17:32 ET · Published

View source

Article summary

Phathom Pharmaceuticals has launched a new patient access program allowing eligible commercially insured patients to obtain VOQUEZNA (vonoprazan) tablets for as little as $0 through its pharmacy network partner, BlinkRx.

An excerpt from the original article.

Related companies

Phathom Pharmaceuticals, Inc. Common StockPHATView stock

Phathom Pharmaceuticals Announces $0 Co-Pay Program for VOQUEZNA via BlinkRx

Article summary

Related companies

Analyzed by WAPE AI.

Comments —